贝伐珠单抗联合化疗治疗难治性实体瘤的疗效和安全性(4)
| 第1页 |
参见附件。
[5]Van Cutsem E，Rivera F，Berry S，et al. Safety and efficacy of first line bevacizumab with FOLFOX，XELOX，FOLFIRI and fluoropyrimidines in metastatic colorectal cancer： the BEAT study [J]. Ann Oncol，2009，20(11)： 1842-1847.
[6]Raez L E， Santos E S， Webb R T， et al. A multicenter phaseⅢ study of docetaxel， oxaliplatin， and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)[J]. Cancer Chemother Pharmacol ......
您现在查看是摘要介绍页，详见PDF附件。